Vanguard Group

Vanguard Group Portfolio holdings

AUM $6.9T Turnover 4.07%
1-Year Est. Return 27.45%
 

The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.

This Fund
S&P 500
This Quarter Est. Return
+14.09%
1 Year Est. Return
+27.45%
3 Year Est. Return
+121.04%
5 Year Est. Return
+156.26%
10 Year Est. Return
+538.59%
AUM
$6.18T
AUM Growth
+$647B
Cap. Flow
+$78.1B
Cap. Flow %
1.26%
Top 10 Hldgs %
28.81%
Holding
4,383
New
103
Increased
2,425
Reduced
1,410
Closed
108
Avg Time Held
8.1 years
Top 10 Avg Time Held
4.8 years
Top 20 Avg Time Held
6 years

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$5.95B
2
NVDA icon
NVIDIA
NVDA
+$4.97B
3
COF icon
Capital One
COF
+$4.5B
4
AMZN icon
Amazon
AMZN
+$3.45B
5
FLUT icon
Flutter Entertainment
FLUT
+$3.39B

Sector Composition

Rank Sector Weight
1 Technology 31.14%
2 Financials 14%
3 Consumer Discretionary 10.14%
4 Healthcare 9.38%
5 Industrials 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
SENEB icon
3626
Seneca Foods Class B
SENEB
$1.25B
$1.51M ﹤0.01%
14,812
+814
+6% +$75.8K
2022 Q1
13 quarters
NDLS icon
3627
Noodles & Co
NDLS
$80.3M
$1.51M ﹤0.01%
264,474
– –
2013 Q3
47 quarters
ADCT icon
3628
ADC Therapeutics
ADCT
$185M
$1.5M ﹤0.01%
560,523
-91,484
-14% -$192K
2024 Q2
4 quarters
UPXI icon
3629
Upexi
UPXI
$84.6M
$1.49M ﹤0.01%
+500,837
New +$4.33M
2025 Q2
0 quarters
TLYS icon
3630
Tilly's
TLYS
$139M
$1.49M ﹤0.01%
1,078,859
-96,715
-8% -$133K
2013 Q2
48 quarters
VNQI icon
3631
Vanguard Global ex-US Real Estate ETF
VNQI
$3.21B
$1.48M ﹤0.01%
32,145
+1,199
+4% +$51.8K
2023 Q1
9 quarters
TACT icon
3632
Transact Technologies
TACT
$47M
$1.48M ﹤0.01%
410,440
– –
2013 Q2
48 quarters
LEE icon
3633
Lee Enterprises
LEE
$151M
$1.48M ﹤0.01%
232,940
-4,325
-2% -$33K
2013 Q2
48 quarters
NRXP icon
3634
NRX Pharmaceuticals
NRXP
$112M
$1.47M ﹤0.01%
452,175
+63,250
+16% +$159K
2021 Q2
16 quarters
SCHB icon
3635
Schwab US Broad Market ETF
SCHB
$44.7B
$1.47M ﹤0.01%
61,804
+4,042
+7% +$89K
2023 Q4
6 quarters
ATRA icon
3636
Atara Biotherapeutics
ATRA
$96M
$1.47M ﹤0.01%
190,761
– –
2014 Q4
42 quarters
APLT icon
3637
DELISTED
Applied Therapeutics
APLT
$1.47M ﹤0.01%
4,734,013
-1,155,180
-20% -$447K
2019 Q3
23 quarters
CLBT icon
3638
Cellebrite
CLBT
$2.72B
$1.47M ﹤0.01%
91,919
+8,712
+10% +$155K
2021 Q4
14 quarters
IMDX icon
3639
Insight Molecular Diagnostics
IMDX
$91.3M
$1.46M ﹤0.01%
483,771
+218,314
+82% +$660K
2016 Q1
37 quarters
MKTW icon
3640
MarketWise
MKTW
$52.9M
$1.45M ﹤0.01%
73,514
+1,080
+1% +$16.6K
2021 Q3
15 quarters
CRWS icon
3641
Crown Crafts
CRWS
$25.6M
$1.45M ﹤0.01%
504,809
– –
2013 Q2
48 quarters
BAER icon
3642
Bridger Aerospace
BAER
$31.7M
$1.45M ﹤0.01%
750,133
-26,646
-3% -$40.9K
2023 Q3
7 quarters
IMMX icon
3643
Immix Biopharma
IMMX
$706M
$1.45M ﹤0.01%
698,537
– –
2022 Q2
12 quarters
BGFV icon
3644
DELISTED
Big 5 Sporting Goods
BGFV
$1.44M ﹤0.01%
1,012,165
-8,874
-0.9% -$9.52K
2013 Q2
48 quarters
LNAI icon
3645
Lunai Bioworks
LNAI
$4.05M
$1.42M ﹤0.01%
61,558
-9,196
-13% -$257K
2019 Q1
25 quarters
HOWL icon
3646
Werewolf Therapeutics
HOWL
$47.6M
$1.42M ﹤0.01%
1,298,251
-211,185
-14% -$217K
2021 Q2
16 quarters
OPHC icon
3647
OptimumBank Holdings
OPHC
$114M
$1.41M ﹤0.01%
316,291
+12,434
+4% +$53.6K
2021 Q1
17 quarters
ERO icon
3648
Ero Copper
ERO
$3.59B
$1.41M ﹤0.01%
83,690
+4,967
+6% +$67.1K
2021 Q2
16 quarters
OMCC
3649
DELISTED
Old Market Capital Corp
OMCC
$1.41M ﹤0.01%
257,249
-3,692
-1% -$20.8K
2013 Q2
48 quarters
KTCC icon
3650
Key Tronic
KTCC
$23.7M
$1.41M ﹤0.01%
492,866
-1,045
-0.2% -$2.77K
2013 Q2
48 quarters

Similar funds

Vanguard Group's Q2 2025 Portfolio in Review

As of Q2 2025, Vanguard Group held 4,383 positions worth $6.18T, up 12% from $5.53T the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Trading was light in Q2 2025: portfolio turnover was 4.8%. Vanguard Group opened 103 new positions and exited 108, leaving the 4,383-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Vanguard Group's largest Q2 2025 buy was Amrize Ltd: 21,350,540 shares worth $1.07B.
  • Vanguard Group added most to Microsoft in Q2 2025, an estimated $5.95B increase.
  • Vanguard Group's biggest Q2 2025 reduction was Amphenol, cutting an estimated $1.18B.
  • Vanguard Group fully exited Discover Financial Services in Q2 2025, selling an estimated $5.32B.
  • Vanguard Group's ten largest holdings make up 29% of its $6.18T portfolio in Q2 2025.
  • Vanguard Group opened 103 new positions and closed 108 in Q2 2025.
  • Vanguard Group's portfolio value rose 12% quarter-over-quarter to $6.18T.

Based on Vanguard Group's 13F filing for Q2 2025, filed 11 Aug 2025.